Oculis Reports Q3 2024 Financial Results and Provides Company Updates
ZUG, Switzerland, Nov. 07, 2024 ( GLOBE NEWSWIRE ) -- Oculis Holding AG ( Nasdaq: OCS. XICE: OCS ) ( "Oculis" or the "Company" ) , a global biopharmaceutical company purposefully driven to save sight and improve eye care, today announced results for the quarter ended September 30, 2024, and ...
| Ticker |
Sentiment |
Impact |
|
AON
|
Neutral
|
21 %
|
|
OCS
|
Somewhat Bullish
|
59 %
|
